Jaideep Dhariwal1, Rachel C Tennant2, David M Hansell2, John Westwick3, Christoph Walker3, Simon P Ward2, Neil Pride2, Peter J Barnes2, Onn Min Kon1, Trevor T Hansel4. 1. Chest and Allergy Department, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London. 2. Departments of Thoracic Medicine, Radiology, and Lung Function and Clinical Studies Unit, National Heart and Lung Institute at the Royal Brompton Hospital, Imperial College, London. 3. Novartis Pharmaceuticals UK Ltd, Horsham, England. 4. Departments of Thoracic Medicine, Radiology, and Lung Function and Clinical Studies Unit, National Heart and Lung Institute at the Royal Brompton Hospital, Imperial College, London. Electronic address: t.hansel@imperial.ac.uk.
Abstract
BACKGROUND: Smoking cessation is of major importance for all smokers; however, in patients with COPD, little information exists on how smoking cessation influences lung function and high-resolution CT (HRCT) scan appearances. METHODS: In this single-center study, we performed screening spirometry in a group of heavy smokers aged 40 to 80 years (N = 358). We then studied the effects of smoking cessation in two groups of selected subjects: smokers with COPD (n = 38) and smokers with normal spirometry (n = 55). In parallel to subjects undergoing smoking cessation, we studied a control group of nonsmokers (n = 19). RESULTS: Subjects with COPD who quit smoking had a marked, but transient improvement in FEV1 at 6 weeks (184 mL, n = 17, P < .01) that was still present at 12 weeks (81 mL, n = 17, P < .05) and only partially maintained at 1 year. In contrast, we saw improvement in the transfer factor of lung for carbon monoxide at 6 weeks in both subjects with COPD who quit smoking (0.47 mmol/min/kPa, n = 17, P < .01) and subjects who quit smoking with normal spirometry (0.40 mmol/min/kPa, n = 35, P < .01). An upper-zone single HRCT image slice reliably identified emphysema at baseline in 74% of smokers with COPD (28 of 38) and 29% of healthy smokers (16 of 55). Smoking cessation had no significant effect on the appearances of emphysema but decreased the presence of micronodules on HRCT imaging. CONCLUSIONS: Cigarette smoking causes extensive lung function and HRCT image abnormalities, even in patients with normal spirometry. Smoking cessation has differential effects on lung function (FEV1 and gas transfer) and features on HRCT images (emphysema and micronodules). Cessation of smoking in patients with COPD causes a transient improvement in FEV1 and decreases the presence of micronodules, offering an opportunity for concomitant therapy during smoking cessation to augment these effects. Smoking cessation at the earliest possible opportunity is vital to minimize permanent damage to the lungs.
BACKGROUND: Smoking cessation is of major importance for all smokers; however, in patients with COPD, little information exists on how smoking cessation influences lung function and high-resolution CT (HRCT) scan appearances. METHODS: In this single-center study, we performed screening spirometry in a group of heavy smokers aged 40 to 80 years (N = 358). We then studied the effects of smoking cessation in two groups of selected subjects: smokers with COPD (n = 38) and smokers with normal spirometry (n = 55). In parallel to subjects undergoing smoking cessation, we studied a control group of nonsmokers (n = 19). RESULTS: Subjects with COPD who quit smoking had a marked, but transient improvement in FEV1 at 6 weeks (184 mL, n = 17, P &lt; .01) that was still present at 12 weeks (81 mL, n = 17, P &lt; .05) and only partially maintained at 1 year. In contrast, we saw improvement in the transfer factor of lung for carbon monoxide at 6 weeks in both subjects with COPD who quit smoking (0.47 mmol/min/kPa, n = 17, P &lt; .01) and subjects who quit smoking with normal spirometry (0.40 mmol/min/kPa, n = 35, P &lt; .01). An upper-zone single HRCT image slice reliably identified emphysema at baseline in 74% of smokers with COPD (28 of 38) and 29% of healthy smokers (16 of 55). Smoking cessation had no significant effect on the appearances of emphysema but decreased the presence of micronodules on HRCT imaging. CONCLUSIONS: Cigarette smoking causes extensive lung function and HRCT image abnormalities, even in patients with normal spirometry. Smoking cessation has differential effects on lung function (FEV1 and gas transfer) and features on HRCT images (emphysema and micronodules). Cessation of smoking in patients with COPD causes a transient improvement in FEV1 and decreases the presence of micronodules, offering an opportunity for concomitant therapy during smoking cessation to augment these effects. Smoking cessation at the earliest possible opportunity is vital to minimize permanent damage to the lungs.
Authors: Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin Journal: Am J Respir Crit Care Med Date: 2012-08-09 Impact factor: 21.405
Authors: R A Pauwels; C G Löfdahl; L A Laitinen; J P Schouten; D S Postma; N B Pride; S V Ohlsson Journal: N Engl J Med Date: 1999-06-24 Impact factor: 91.245
Authors: B W M Willemse; N H T ten Hacken; B Rutgers; I G A T Lesman-Leegte; D S Postma; W Timens Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: Shoshana B Ginsburg; Jason Zhao; Stephen Humphries; Sungshick Jou; Kunihiro Yagihashi; David A Lynch; Joyce D Schroeder Journal: Acad Radiol Date: 2016-08-27 Impact factor: 3.173
Authors: Martin Chaumont; Vanessa Tagliatti; El Mehdi Channan; Jean-Marie Colet; Alfred Bernard; Sofia Morra; Guillaume Deprez; Alain Van Muylem; Nadia Debbas; Thomas Schaefer; Vitalie Faoro; Philippe van de Borne Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-11-13 Impact factor: 5.464
Authors: Giovanna De Cunto; Simone De Meo; Barbara Bartalesi; Eleonora Cavarra; Giuseppe Lungarella; Monica Lucattelli Journal: Int J Mol Sci Date: 2022-08-14 Impact factor: 6.208
Authors: Blaine Phillips; Emilija Veljkovic; Stéphanie Boué; Walter K Schlage; Gregory Vuillaume; Florian Martin; Bjoern Titz; Patrice Leroy; Ansgar Buettner; Ashraf Elamin; Alberto Oviedo; Maciej Cabanski; Héctor De León; Emmanuel Guedj; Thomas Schneider; Marja Talikka; Nikolai V Ivanov; Patrick Vanscheeuwijck; Manuel C Peitsch; Julia Hoeng Journal: Toxicol Sci Date: 2015-11-25 Impact factor: 4.849
Authors: Alayna P Tackett; Brittney Keller-Hamilton; Caitlin E Smith; Emily T Hébert; Jordan P Metcalf; Lurdes Queimado; Elise M Stevens; Samantha W Wallace; Elizabeth L McQuaid; Theodore L Wagener Journal: JAMA Netw Open Date: 2020-10-01